Abeona Therapeutics (ABEO) Enterprise Value (2010 - 2026)

Abeona Therapeutics' Enterprise Value history runs 17 years deep, the most recent figure standing at -$168.3 million for Q1 2026.

• In Q1 2026, Enterprise Value fell 99.95% year-over-year to -$168.3 million; the TTM figure through Mar 2026 stood at -$168.3 million (down 99.95% YoY), while the FY2025 annual figure was -$191.4 million, down 95.19% from the prior year.
• Enterprise Value was -$168.3 million for Q1 2026 at Abeona Therapeutics, up from -$191.4 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$18.2 million in Q3 2022 to a low of -$225.9 million in Q2 2025.
• Historically, Enterprise Value has averaged -$93.5 million across 5 years, with a median of -$62.3 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Enterprise Value surged 73.27% in 2022, then tumbled 231.57% in 2024.
• A 5-year view of Enterprise Value shows it stood at -$52.5 million in 2022, then fell by 0.15% to -$52.6 million in 2023, then sank by 86.55% to -$98.1 million in 2024, then tumbled by 95.19% to -$191.4 million in 2025, then advanced by 12.09% to -$168.3 million in 2026.
• The last three Enterprise Value figures came in at -$168.3 million (Q1 2026), -$191.4 million (Q4 2025), and -$207.5 million (Q3 2025), per Business Quant data.